SSA
XBI icon

Schonfeld Strategic Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$976K Buy
+7,643
New +$954K 0.01% 1107
2025
Q4 		– Sell
-177,753
Closed -$17.8M – 2663
2025
Q3 		$17.8M Buy
177,753
+159,827
+892% +$14.4M 0.1% 213
2025
Q2 		$1.49M Buy
+17,926
New +$1.43M 0.01% 1132
2025
Q1 		– Sell
-7,155
Closed -$644K – 2525
2024
Q4 		$644K Buy
7,155
+7,154
+715,400% +$693K ﹤0.01% 1301
2024
Q3 		$98 Sell
1
-173,874
-100% -$17.1M ﹤0.01% 1986
2024
Q2 		$16.1M Sell
173,875
-1,074
-0.6% -$96.3K 0.1% 219
2024
Q1 		$16.6M Sell
174,949
-51,044
-23% -$4.74M 0.11% 218
2023
Q4 		$20.2M Sell
225,993
-131,797
-37% -$9.79M 0.13% 160
2023
Q3 		$26.1M Sell
357,790
-14,959
-4% -$1.19M 0.2% 131
2023
Q2 		$31M Buy
372,749
+66,943
+22% +$5.6M 0.27% 96
2023
Q1 		$23.3M Buy
305,806
+16,510
+6% +$1.37M 0.22% 126
2022
Q4 		$24M Buy
289,296
+13,458
+5% +$1.09M 0.2% 134
2022
Q3 		$21.9M Buy
275,838
+232,450
+536% +$19.6M 0.18% 142
2022
Q2 		$3.22M Sell
43,388
-12,300
-22% -$923K 0.03% 598
2022
Q1 		$5M Buy
55,688
+45,989
+474% +$4.25M 0.05% 451
2021
Q4 		$1.09M Buy
9,699
+8,602
+784% +$1.04M 0.01% 895
2021
Q3 		$138K Buy
+1,097
New +$141K ﹤0.01% 1868
2021
Q2 		– Sell
-27,366
Closed -$3.71M – 2358
2021
Q1 		$3.71M Buy
+27,366
New +$4.1M 0.05% 513
2020
Q4 		– Sell
-1
Closed – – 1915
2020
Q3 		$0 Buy
+1
New +$112 ﹤0.01% 1711

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Schonfeld Strategic Advisors's XBI Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 7,643 shares worth $976K. The stake represents 0.01% of the portfolio and ranks #1107 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in XBI as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in XBI in Q3 2020 and has held it in 19 quarters since. The position peaked at $31M in Q2 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Schonfeld Strategic Advisors held 7,643 shares of State Street SPDR S&P Biotech ETF worth $976K as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Schonfeld Strategic Advisors position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1107 holding.
  • Schonfeld Strategic Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 19 quarters since.
  • Schonfeld Strategic Advisors's State Street SPDR S&P Biotech ETF position peaked at $31M in Q2 2023.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.